Jiangxi Hongyuan Pharmaceutical Co., Ltd. Sustainability Profile
Jiangxi Hongyuan Pharmaceutical Co., Ltd., commonly referred to as Hongyuan Pharma, is a prominent player in the pharmaceutical industry, headquartered in Jiangxi, China. Established in 2001, the company has made significant strides in the development and production of high-quality pharmaceutical products, particularly in the fields of traditional Chinese medicine and modern pharmaceuticals. With a strong operational presence across various regions in China, Hongyuan Pharma is renowned for its innovative formulations and commitment to research and development. The company’s core offerings include a diverse range of active pharmaceutical ingredients (APIs) and finished dosage forms, distinguished by their efficacy and safety profiles. Recognised for its dedication to quality and compliance with international standards, Jiangxi Hongyuan Pharmaceutical has positioned itself as a trusted supplier in both domestic and global markets, achieving notable milestones in product development and market expansion.
DitchCarbon Score
How does Jiangxi Hongyuan Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Jiangxi Hongyuan Pharmaceutical Co., Ltd.'s score of 20 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Jiangxi Hongyuan Pharmaceutical Co., Ltd.'s reported carbon emissions
Jiangxi Hongyuan Pharmaceutical Co., Ltd., headquartered in China (CN), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. As there are no emissions data or reduction initiatives available, it is unclear how Jiangxi Hongyuan Pharmaceutical aligns with industry standards for climate action. The absence of emissions reporting may reflect a broader trend within the pharmaceutical sector, where companies are increasingly being urged to disclose their carbon footprints and set ambitious targets in line with global climate goals. In summary, Jiangxi Hongyuan Pharmaceutical Co., Ltd. currently lacks specific emissions data and formal climate commitments, positioning it within an industry context that is progressively prioritising sustainability and transparency.
How Carbon Intensive is Jiangxi Hongyuan Pharmaceutical Co., Ltd.'s Industry?
How Carbon Intensive is Jiangxi Hongyuan Pharmaceutical Co., Ltd.'s Location?
Jiangxi Hongyuan Pharmaceutical Co., Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Jiangxi Hongyuan Pharmaceutical Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
